HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-metastatic Efficacy of Traditional Chinese Medicine (TCM) Ginsenoside Conjugated to a VEFGR-3 Antibody on Human Gastric Cancer in an Orthotopic Mouse Model.

Abstract
Background/Aim: The aim of the present study was to investigate the efficacy of a traditional Chinese medicine (TCM), VEGFR-3 antibody-conjugated ginsenoside Rg 3 nanoemulsion (VRIN), targeting lymphangiogenesis, on the inhibition of tumor growth and metastasis in an orthotopic mouse model of human gastric cancer. Materials and Methods: An orthotopic nude-mouse model of gastric cancer was established with the red fluorescent protein (RFP)-expressing human gastric cancer cell line NUGC-4-RFP. The tumor-bearing mice were treated with vehicle (0.2 ml normal saline every other day, iv), 5-FU (20 mg/kg once a week, i.p.) and VRIN (1 mg/kg every other day, i.v.). Real-time fluorescence imaging was performed to assess tumor inhibition in each group. Metastasis was evaluated by open fluorescence imaging at autopsy. The expression of lymphangiogenesis-related factors VEGF-C, VEDF-D and VEGFR-3 in the tumors were analyzed by immunohistochemistry and real-time RCP. Results: VRIN and 5-FU significantly inhibited primary tumor growth as compared to vehicle control (p<0.05). However, significant inhibition of lymph-node metastasis was only found in the VRIN-treated group (p<0.05). The expression of VEGF-C, VEGF-D and VEGFR-3 in the tumor was suppressed by VRIN treatment (p<0.05). Expression of VEGF-D and VEGFR-3 in the 5-FU-treated group was not significantly increased (p>0.05). No obvious toxicity was found in VRIN- and 5-FU-treated groups. Conclusion: Lymphangiogenesis-targeted ginsenoside Rg 3 immune-nanoemulsion inhibited tumor growth and reduced lymphatic metastasis by suppressing expression of VEGF-C, VEGF-D and VEGFR-3 in an orthotopic mouse model of human gastric cancer. Our study demonstrates the potential of TCM as an effective targeted treatment for metastatic gastric cancer.
AuthorsXiaojun Dai, Dongmei Liu, Moxiang Liu, Xiaochun Zhang, Weiming Wang, Feng Jin, Yayun Qian, Xuanyi Wang, Jingjing Zhao, Yongjian Wu, Fangfang Xiong, N A Chang, Y U Sun, Zhijian Yang, Robert M Hoffman, Yanqing Liu
JournalAnticancer research (Anticancer Res) Vol. 37 Issue 3 Pg. 979-986 (03 2017) ISSN: 1791-7530 [Electronic] Greece
PMID28314255 (Publication Type: Journal Article)
CopyrightCopyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Chemical References
  • Antibodies
  • Antineoplastic Agents
  • Drugs, Chinese Herbal
  • Ginsenosides
  • Luminescent Proteins
  • Nanoconjugates
  • red fluorescent protein
  • FLT4 protein, human
  • Vascular Endothelial Growth Factor Receptor-3
  • Fluorouracil
Topics
  • Animals
  • Antibodies (administration & dosage)
  • Antineoplastic Agents (administration & dosage)
  • Cell Line, Tumor
  • Drugs, Chinese Herbal (administration & dosage, therapeutic use)
  • Female
  • Fluorouracil (chemistry)
  • Ginsenosides (administration & dosage)
  • Humans
  • Luminescent Proteins (metabolism)
  • Lymphangiogenesis
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Microscopy, Fluorescence
  • Nanoconjugates (chemistry)
  • Neoplasm Metastasis
  • Neoplasm Transplantation
  • Stomach Neoplasms (drug therapy, immunology)
  • Vascular Endothelial Growth Factor Receptor-3 (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: